Our Focus

Innovation guided by patients'
unmet medical needs.

Taking strides
in cns disease

At Mitsubishi Tanabe Pharma America, we are driven to address the needs of those with central nervous system disorders.

We plan to support these communities by introducing high-quality products and innovative solutions.

Addressing challenges
in rare diseases

We are working toward scientific advancements in the treatment of rare and other diseases that have high, unmet medical needs.

These disabling and often life-threatening conditions are regularly overlooked and underserved.

We plan to engage in disease education, clinical research, and community partnerships to give people with these diseases the attention and support they deserve.

Their inspiration.
Our innovation.

Refining the focus
on ALS

We are motivated by the remarkable determination and resourcefulness it takes for both people with amyotrophic lateral sclerosis (ALS) and their loved ones to fight back against ALS, a rapidly progressive neurodegenerative disease.

Our current efforts are focused on advancing the treatment of people who are living with this debilitating condition.

Learn about our FDA-approved prescription medicine available to treat people with ALS.